In her last year of residency, Jill Huded, MD, created new educational handouts for CommunityHealth, a free clinic in Chicago, to increase health literacy in an underserved population. Her project was funded by a Schweitzer fellowship.
Published online in the journal Medical Informatics, the research found that doctors who use electronic health records in the exam room spend about a third of their visits looking at a computer screen, missing out on nonverbal cues from patients.
Hossein Ardehali, MD, PhD, has discovered that doxorubicin, an effective and commonly used anticancer drug, is causing an accumulation of iron inside of a cell’s mitochondria, resulting in heart damage.
After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells that rush to the scene of the oxygen-starved tissue. But the damage is slashed in half when microparticles are injected into the blood stream within 24 hours of the attack, according to preclinical research.
Northwestern Medicine scientists have developed a new prognostic tool for clinicians treating patients with large B-cell lymphoma. The predictive scale enhances the widely used International Prognostic Index.
Richard J. Gannotta, DHA, FACHE, will work closely with the leadership of Northwestern Memorial HealthCare and Northwestern University Feinberg School of Medicine to advance Northwestern Medicine.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has named Deputy Director Leonidas Platanias, MD, PhD, professor of Medicine-Hematology/Oncology, interim director, effective immediately.
The guidelines – released from the American College of Cardiology and the American Heart Association – will help doctors better identify which patients may benefit from lifestyle changes, drug therapy, or both to help prevent future cardiovascular disease-related events.
A new algorithm developed by an interdisciplinary team at Northwestern can be used with a physical activity app to predict the location of a phone no matter where an individual carries it.
A distinguished physician-scientist and international leader in the treatment of inflammatory bowel disease, Stephen B. Hanauer, MD, will join the medical school on January 1, 2014, as the Clifford Joseph Barborka Professor of Medicine and the medical director of the Digestive Disease Center.